Home/Filings/4/0001415889-24-005107
4//SEC Filing

Morrone Louis H. 4

Accession 0001415889-24-005107

CIK 0000001800other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:40 PM ET

Size

8.3 KB

Accession

0001415889-24-005107

Insider Transaction Report

Form 4
Period: 2024-02-21
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
Transactions
  • Award

    Common shares without par value

    2024-02-21+12,30967,224 total
  • Award

    Option (right to buy)

    2024-02-21+46,25746,257 total
    Exercise: $116.98From: 2025-02-21Exp: 2034-02-20Common Shares (46,257 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    2,556
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2024.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,419 on February 21, 2025, 15,419 on February 21, 2026, and 15,419 on February 21, 2027.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001867666

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:40 PM ET
Size
8.3 KB